LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

InterVene

The first non-implantable, catheter-based therapy to treat the valvular pathophysiology of chronic venous insufficiency in the deep veins.

Get a Demo and See the Full Profile

Get a demo today to see profiles of InterVene plus 6131 other startups.

Learn More About InterVene

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups

More